EICHOR
● Completed
Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease
Condition: Superficial Femoral Artery Disease · Popliteal Artery Disease · Sponsor: Terumo Europe N.V.
About this study
The primary objective of this study is to confirm the safety and efficacy of the RenzanTM Peripheral Stent System when used for treatment of superficial femoral (SFA) and/or popliteal (POP) artery disease. This trial plans to include 135 patients in (up to) 10 locations around in Europe.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (13)
| AZ Sint-Blasius | Dendermonde, Oost-Vlaanderen, Belgium | — |
| Onze Lieve Vrouw (OLV) Ziekenhuis | Aalst, Belgium | — |
| Imelda ziekenhuis | Bonheiden, Belgium | — |
| Ziekenhuis Oost Limburg | Genk, Belgium | — |
| Clinique Rhône-Durance | Avignon, France | — |
| Hôpital Paris Saint-Joseph | Paris, France | — |
| Clinique Saint Jean - Sud de France | Saint-Jean-de-Védas, France | — |
| Klinikum Hochsauerland Karolinen-Hospital Hüsten | Arnsberg, Germany | — |
| CCB MVZ Frankfurt und Main-Taunus GbR | Frankfurt, Germany | — |
| Elblandklinikum Radebeul | Radebeul, Germany | — |
| Diakonessenhuis | Utrecht, Netherlands | — |
| Hospital Germans Trias i Pujol | Badalona, Spain | — |
+ 1 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04546477